Showing results (231-240 of 286) with videos related to
Sort By:
Pageof 29
Nature Medicine|April 5, 2011
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapyEric A Collisson, Anguraj Sadanandam, Peter Olson, et al.JAMA Oncology|February 15, 2017
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033Michael C Heinrich, Cathryn Rankin, Charles D Blanke, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumorMichael C Heinrich, Christopher L Corless, George D Demetri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 27, 2023
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal TumorMichael C Heinrich, Christopher L Corless, George D Demetri, et al.Archives of Pathology & Laboratory Medicine|August 4, 2006
Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experienceGeorge J Netto, David L Watkins, James W Williams, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic ResponseMayra Yebra, Shruti Bhargava, Avi Kumar, et al.The Journal of Pathology|November 6, 2009
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumoursSubbaya Subramanian, Venugopal Thayanithy, Robert B West, et al.BMC Bioinformatics|November 8, 2006
A simple spreadsheet-based, MIAME-supportive format for microarray data: MAGE-TABTim F Rayner, Philippe Rocca-Serra, Paul T Spellman, et al.The Journal of Molecular Diagnostics : JMD|December 15, 2019
Multi-Institutional Evaluation of Interrater Agreement of Variant Classification Based on the 2017 Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in CancerDeepika Sirohi, Robert L Schmidt, Dara L Aisner, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2015
Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT InhibitionRichard D Carvajal, Donald P Lawrence, Jeffrey S Weber, et al.Pageof 29